| 1 |
Bansi Lal Kaul |
Clariant Finance (Bvi) Limited |
10 |
| 2 |
Alexander Alanine |
Hoffmann-La Roche |
7 |
| 3 |
Georg Jaeschke |
Hoffmann-La Roche |
5 |
| #4 |
Josef Dannacher |
Ciba Specialty Chemicals |
4 |
| #4 |
Karl-Heinz Altmann |
Novartis Ag |
4 |
| #6 |
Rolf Wiesendanger |
Huntsman Advanced Materials Americas |
3 |
| #7 |
Barbara Hohn |
Ciba-Geigy |
2 |
| #7 |
Rolf Deitz |
Ciba-Geigy |
2 |
| #7 |
Urs Lehmann |
Ciba Specialty Chemicals |
2 |
| #7 |
Johann Schuster |
Siemens Aktiengesellschaft |
2 |
| #7 |
Peter Wintergerst |
Euro-Celtique S.A. |
2 |
| #7 |
Ivan Orban |
Ciba-Geigy |
2 |
| #7 |
Heinz Stadler |
Hoffmann-La Roche |
2 |
| #7 |
Andreas Manz |
Zeptosens Ag |
2 |
| #7 |
Laurenz Gsell |
Ciba-Geigy |
2 |
| #7 |
Hans-Peter Marki |
Hoffmann-La Roche |
2 |
| #7 |
Otto Hartmann |
Novartis Ag |
2 |
| #7 |
Christian Schutze |
Endress+Hauser Flowtec Ag |
2 |
| #7 |
Anna Vulpetti |
Novartis Ag |
2 |
| #7 |
John S. Zambounis |
Ciba Specialty Chemicals |
2 |
| #7 |
Andre Gehrig |
Euro-Celtique S.A. |
2 |
| #22 |
Gerhard Penn |
Novartis Ag |
1 |
| #22 |
Aaldert Molenberg |
Straumann Holding Ag |
1 |
| #22 |
Philip Huxley |
British Biotech Pharmaceuticals |
1 |
| #22 |
Manfred Kohlmeyer |
Novartis Ag |
1 |
| #22 |
Hans-Peter Maerki |
Hoffmann-La Roche |
1 |
| #22 |
Francois Jean-Charles Natt |
Novartis Ag |
1 |
| #22 |
Paul Cutler |
Hoffmann-La Roche |
1 |
| #22 |
Natacha Bonnard Pillonel |
Ciba Specialty Chemicals |
1 |
| #22 |
Kurt Puntener |
Roche Vitamins |
1 |
| #22 |
Enrico Schneider |
— |
1 |
| #22 |
Peter Oroszlan |
Novartis Ag |
1 |
| #22 |
Manfred Rembold |
Ciba-Geigy |
1 |
| #22 |
Søren Skov |
Xcyte Therapies |
1 |
| #22 |
Frank Schaefer |
Robert Bosch Gmbh |
1 |
| #22 |
Anthony Cornelius O'Sullivan |
Syngenta Crop Protection Ag |
1 |
| #22 |
Jean-Christophe Graciet |
Unknown |
1 |
| #22 |
Lassi Karvonen |
Omya International Ag |
1 |
| #22 |
Beat Freiermuth |
Ciba Specialty Chemicals |
1 |
| #22 |
Jurg Speich |
Ciba-Geigy |
1 |
| #22 |
Robert Karl Muller |
Roche Vitamins |
1 |
| #22 |
Roberto Cudini |
Endress+Hauser |
1 |
| #22 |
Thomas Weller |
Hoffmann-La Roche |
1 |
| #22 |
Jacques Chollet |
Medicines For Malaria Venture |
1 |
| #22 |
Konrad Tagwerker |
Synthes Usa |
1 |
| #22 |
Arnold Gloor |
Dsm Ip Assets B.V. |
1 |
| #22 |
Josef Stadlwieser |
Hoffmann-La Roche |
1 |
| #22 |
René Heckendorn |
Gaba International Holding Gmbh |
1 |
| #22 |
Jean Ackermann |
Hoffmann-La Roche |
1 |
| #22 |
Richard Sedrani |
Novartis Ag |
1 |